Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?

P S Sorensen, Nils Koch-Henriksen, Esben Meulengracht Flachs, K Bendtzen

25 Citationer (Scopus)

Abstract

To establish whether multiple sclerosis (MS) patients, who have lost the therapeutic effect of interferon-beta (IFN-beta) owing to neutralizing antibodies (NAbs) and subsequently revert from a NAb-positive to a NAb-negative state under continued IFN-beta-1b therapy, regain clinical effect after reversion.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind14
Udgave nummer6
Sider (fra-til)837-42
Antal sider6
ISSN1352-4585
DOI
StatusUdgivet - 1 jul. 2008
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?'. Sammen danner de et unikt fingeraftryk.

Citationsformater